Back
Novo Nordisk A/S 10K Form
Buy
53
NONOF
Novo Nordisk A/S
Last Price:
124.15
Seasonality Move:
5.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NONOF News And Ratings
See the #1 stock for the next 7 days that we like better than NONOF
NONOF Financial Statistics
Sales & Book Value
| Annual Sales: | $25.09B |
|---|---|
| Cash Flow: | $3.2B |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.95 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 3.80110 |
|---|---|
| Net Income (TTM): | $9.52B |
| Gross Margin: | $21.05B |
| Return on Equity: | 82.75% |
| Return on Assets: | 27.17% |
Novo Nordisk A/S Earnings Forecast
Key Novo Nordisk A/S Financial Ratios
- The Gross Profit Margin over the past 39 years for NONOF is 83.92%.
- The Selling, General & Administrative Expenses for NONOF have been equal to 28.64% of Gross Profit Margin.
- The Research & Development expenses have been 13.59% of Revenue.
- The Interest Expense is 0.68% of Operating Income.
- The Net Earning history of NONOF is 31.38% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 34 years.
Novo Nordisk A/S Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NONOF |
| Website: | novonordisk.com |
Debt
| Debt-to-Equity Ratio: | 0.28 |
|---|---|
| Current Ratio: | 0.88 |
| Quick Ratio: | 0.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NONOF Technical Analysis vs Fundamental Analysis
Buy
53
Novo Nordisk A/S (NONOF)
is a Buy
Is Novo Nordisk A/S a Buy or a Sell?
-
Novo Nordisk A/S stock is rated a Buy
The current Novo Nordisk A/S [NONOF] share price is $122.74. The Score for NONOF is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.